FRI0195 Point-of-care monitoring of anti-infliximab antibodies in patients treated with the reference infliximab or ct-p13 in routine clinical practice
FRI0195 Point-of-care monitoring of anti-infliximab antibodies in patients treated with the reference infliximab or ct-p13 in routine clinical practice